TUFM is highly expressed in several cancers including glioblastoma, cholangiocarcinoma, and colorectal cancer (CRC) [42–44], and increased expression of TUFM is associated with shorter patient survival in CRC[45]. Here, TUFM is linked to glioblastoma.